Marinus Pharmaceuticals | Kortsiktig Gjeld

Current Liabilities Endring Dato
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Amgen USD 18.39B 1.44B 2023-12
Eisai JPY 307.31B 11.44B 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
Incyte USD 1.24B 115.7M 2023-12
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12
UCB EUR 2.65B 464M 2023-06
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Marinus Pharmaceuticals Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.